| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,139,807 | 840,055 | 629,393 | 624,170 | | Cost of Revenue | 651,971 | 315,392 | 277,669 | 443,211 | | | Gross Profit | 487,836 | 524,663 | 351,724 | 180,959 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 250,894 | 266,865 | 248,126 | 43,600 | | Non Recurring | (211,938) | 632 | 211,306 | 53,250 | | Others | 102,271 | 100,063 | 99,921 | 98,399 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 346,609 | 157,103 | (207,629) | (14,290) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,723 | 7,130 | (4,369) | (5,020) | | Earnings Before Interest And Taxes | 351,332 | 164,233 | (211,998) | (19,310) | | Interest Expense | 58,805 | 55,640 | 51,972 | 54,483 | | Income Before Tax | 292,527 | 108,593 | (263,970) | (73,793) | | Income Tax Expense | 103,881 | 37,600 | (96,174) | (27,082) | | Minority Interest | 14,944 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 203,590 | 70,993 | (167,796) | (46,711) | | | Non-recurring Events | | Discontinued Operations | (2,576) | (2,798) | (2,924) | 7,861 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 201,014 | 68,195 | (170,720) | (38,850) | | Preferred Stock And Other Adjustments | (14,362) | 152 | 14,210 |
-
| | | Net Income Applicable To Common Shares | $186,652 | $68,347 | ($156,510) | ($38,850) |
|
0.03% Nasdaq 
0.27 (0.72%) 
Income Statement
